Essential thrombocythemia is chronic myeloproliferative neoplasia, as
defined by WHO in 2016, with the best prognosis. A small percentage of
ET cases can be considered Familial ET. In this report we describe 6
cases of Familial ET, evaluating the heterogeneity of the mutational
state and the clinical presentation.